Annexin Pharma: Outcome of Warrant Program Announced - Redeye
Redeye comments on yesterday’s announcement regarding the outcome of Annexin’s TO3 warrant program. We resume our coverage and slightly adjust our base case
ANNONS
Redeye comments on yesterday’s announcement regarding the outcome of Annexin’s TO3 warrant program. We resume our coverage and slightly adjust our base case